Get the dataData

GRAWE neživotno

GRAWE groupMontenegrograwe.me ↗#6 of 9 in Montenegro, FY 2025
Updated 11 Nov 2026
Sources and updates
Source
ANO market reports and insurers' annual reports; solvency margin, not Solvency II
Latest figures
FY 2025, Jan–Sep 2026
Next update
FY 2026, around May 2027

Sources for MontenegroWhat changed

Compare with nearest rivals →Compare →
Share
Premium
€12m
8.0% of Montenegro
Growth
+15.4%
FY 2025 vs 2024, in EUR · market +10.5%
Life share
0%
of own premium
Capital cover
392%
Solvency margin · €7.3m held vs €1.9m required
Claims and costs
95%
combined ratio after reinsurance · gross 84% · market 96%
In shortNumber 6 of 9 in Montenegro with 8.0% of premium, growing faster than the market. Strongest in Casco, with 17.5% of the line. Its non-life business made money on underwriting, with a combined ratio of 95% after reinsurance against 96% for the market. It paid €5.5m in claims, €46 for every €100 of its premium. It covers its required solvency margin 3.9 times.

Latest resultsJan–Sep 2026, year to date: €11m of premium, +27.0% on Jan–Sep 2025 (market +12.8%); share 8.9% (+1.0 pp), #5 of 11. More

Fingerprint

GRAWE neživotno's line mix, and where it stands among the 9 insurers in Montenegro on each measure, FY 2025.

Line mix
Motor TPL47%
Casco19%
Accident15%
Property9%
Health7%
Other non-life2%
Liability1%
Size#6 of 9 by premium
€12m
larger than 38%median €14m
GrowthFY 2025 against 2024, in EUR
+15.4%
ahead of 75%median +13.8%
Claims and costsnon-life combined ratio, after reinsurance
95%
better than 50%median 95%
Capital coverlocal solvency margin
392%
ahead of 50%median 392%
Return on equitynet profit ÷ average equity
12.6%
ahead of 50%median 12.6%

Each bar runs from the weakest to the strongest of the insurers in Montenegro with that figure in FY 2025; the dot is this insurer, the tick in the middle the median. Combined ratios as shown across the site: after reinsurance where published, else gross. The rose: each petal's area is the line's share of written premium; the dashed ring is a quarter.

Premium and market share

Market share against the nearest rivals

By year

Insurer20212022202320242025
Lovćen34.4%33.3%30.5%29.7%27.7%
Sava14.6%16.1%17.3%16.9%17.6%
UNIQA neživotno12.2%13.0%14.4%14.8%16.0%
Generali11.4%11.3%10.7%10.3%9.9%
GRAWE neživotno7.1%6.6%7.3%7.6%8.0%

Lines and claims

Written premium by line with ratios after reinsurance for the year selected (gross, marked, where the insurer gives no net figures for a line); the market figure on the same basis sits under each ratio.

All figures

Solvency

DetailsCapital in detailOwn funds against the capital requirement, and the risks it covers

Capital at year end

Capital cover

    Also in the GRAWE group

    14 companies in 10 markets · €686m premium, latest year

    All 14 on the GRAWE page →
    Montenegrothis market1 company€7.6m
    GRAWE€7.6m
    Romania1 company€222m
    GRAWE€222m
    Slovenia1 company€105m
    GRAWE zavarovalnica€105m
    Croatia1 company€80m
    GRAWE Hrvatska€80m
    Serbia1 company€66m
    GRAWE Osiguranje€66m

    Also in Bosnia and Herzegovina · €54mMoldova · €31mHungary · €30mBulgaria · €23m

    Company details

    Legal name
    Osiguravajuce drustvo "GRAWE nezivotno osiguranje" A.D. Podgorica
    Registered seat
    Podgorica, Montenegro
    Website
    grawe.me
    LEI
    529900S26HFUQ0952H23
    Employees
    72 (2025; 35 in 2022, 64 in 2024)
    Premium per employee
    €164k (FY 2025; median for non-life insurers in Montenegro: €175k; all insurers)

    Legal name, seat and LEI from the Global LEI Index (GLEIF); website from the company's own reports or the supervisor's register, checked 20 Oct 2026.

    Questions about GRAWE neživotno

    Short answers from the figures on this page.

    What is GRAWE neživotno's market share in Montenegro?

    GRAWE neživotno wrote €11.8m of premium in FY 2025, 8.0% of all premium in Montenegro, ranking #6 of 9 insurers; its premium grew 15.4% on FY 2024.

    Who owns GRAWE neživotno?

    GRAWE neživotno is part of the GRAWE group, which has 14 companies in 10 of the 18 markets on Polisa (FY 2025).

    What does GRAWE neživotno sell?

    GRAWE neživotno is a non-life insurer; its largest lines in FY 2025 are motor TPL (47.2% of its premium), casco (19.4%) and accident (14.7%).

    Is GRAWE neživotno well capitalised?

    GRAWE neživotno's solvency margin was 392% at 31 December 2025: it covered its required solvency margin 3.9 times, against a median of 392% for the insurers in Montenegro (local rules, not Solvency II).

    Is GRAWE neživotno profitable?

    GRAWE neživotno made a net profit of €0.978m in FY 2025, a return on equity of 12.6%; its non-life combined ratio was 95% after reinsurance.

    Is GRAWE neživotno growing?

    GRAWE neživotno's premium grew 15.4% in FY 2025, faster than the market in Montenegro (+10.5%).

    Sources for this page

    Premium: ANO (Insurance Supervision Agency of Montenegro), quarterly market reports. Lines, claims and solvency margin: the insurer's annual report and ANO. How these numbers are built.

    Spotted a wrong figure? Tell us and include the source.

    CiteCite this pageThe reference in APA style and as BibTeX, each with a copy button, and the terms of reuse

    Polisa compiles the figures; the original sources are named on this page and on the method page.

    APA

    Polisa. (2026). GRAWE neživotno (Montenegro): premium, market share, lines, solvency and claims [Data version 2026-11-11.13378f]. Retrieved November 11, 2026, from https://polisapro.com/insurers/me-grawe-nezivotno

    BibTeXShow entry
    Entry for a .bib file
    @misc{polisa_insurers_me_grawe_nezivotno_2026,
      author       = {{Polisa}},
      title        = {GRAWE neživotno (Montenegro): premium, market share, lines, solvency and claims},
      year         = {2026},
      version      = {2026-11-11.13378f},
      howpublished = {\url{https://polisapro.com/insurers/me-grawe-nezivotno}},
      note         = {Accessed 11 November 2026}
    }

    Reuse: Polisa's compilation CC BY 4.0 · source data: ANO (public information, no terms published).